Clinical Trial Update: Chiglitazar/Metformin in Non-obese Women With PCOS [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial of chiglitazar combined with metformin in non-obese women with polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Chiglitazar (Chiglitazar)
• metformin (metformin)

Snippet

Sponsor: Shengjing Hospital | Conditions: Polycystic Ovary Syndrome, Chiglitazar | Phase 2, Phase 3 | Status: COMPLETED